GSK
GSK plc
Stock
$47.03−0.15 (−0.32%)Close Oct 2, 2026
- Stock-based compensation, FY2025
- £374M
- YoY, FY2025
- +8.7%
- 5-year CAGR
- +2.1%
- 10-year CAGR
- +0.2%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| FY2025 | £374M | +8.7% |
| FY2024 | £344M | +12.1% |
| FY2023 | £307M | −11.3% |
| FY2022 | £346M | +0.9% |
| FY2021 | £343M | +1.8% |
| FY2020 | £337M | −7.7% |
| FY2019 | £365M | +1.4% |
| FY2018 | £360M | +8.1% |
| FY2017 | £333M | +4.4% |
| FY2016 | £319M | −13.3% |
| FY2015 | £368M | — |